baber/WOPTO huggingface dataset:
Patent DE-69533940-T2 (DE)
Inventor: KAESEMEYER WAYNE H
IPC: A61K38/095
Filed: 1995-10-05
Granted: 2005-12-22
Abstract: A therapeutic mixture comprising a mixture of a venous dilator, selected from isosorbide dinitrate and isosorbide 5'-mononitrate, and an arterial dilator such as L-arginine, is disclosed for the treatment of diseases related to vasoconstriction, wherein the vasoconstriction is relieved by stimulating the constitutive form of nitric oxide synthase (cNOS) to produce native nitric oxide (NO). The native NO having superior beneficial effect when compared to exogenous NO produced by a L-arginine independent pathway in terms of the ability to reduce clinical endpoints and mortality.
Patent DE-69535737-T2 (DE)
Inventor: HIRANO MUNEHIKO
IPC: A61K9/70
Filed: 1995-09-11
Granted: 2009-04-09
Abstract: A patch for external use comprising an antiphlogistic having carboxylic groups in its molecule, 1-menthol and a metal salt of a fatty acid.
Patent DE-69603010-T2 (DE)
Inventor: KHAMBAY BHUPINDER PALL SINGH
IPC: A01N37/42
Filed: 1996-01-10
Granted: 1999-10-28
Abstract: Pesticidal compounds having general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alkyl, alkenyl, haloalkyl, haloalkenyl, alkoxy, haloalkoxy, haloalkenoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, aryl or aralkyl group; R<1> and R<2> each independently represent an optionally substituted alkoxy group or together represent a group =O, =S or =N-OR<9>, where R<9> represents a hydrogen atom or an optionally substituted alkyl group; R<3> represents a hydroxyl group, or a group -OL where L is a leaving group, or a group which in vivo is transformed into a group -OL<1> where L<1> is a leaving group; R<6> represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyloxy, cycloalkenyloxy or aryloxy group; R<7> and R<8> independently represent an optionally substituted alkoxy group or together represent a group =O, =S or =N-OR<9>, where R<9> is as previously defined; wherein R4 and R5 independently represent a halogen atom or an optionally substituted alkyl or alkenyl group, or together with the interjacent carbon atom represent an optionally substituted cylcoalkyl or cycloalkenyl ring; and A represents a straight or branched chain alkyl or alkenyl group, which may be optionally substituted, preferably with halogen, an acyclic carbon chain of which links the 3 position of the naphthalene ring shown and the moiety -CR<4>R<5>R<6>; with the proviso that when R<1> and R<2>, and R<7> and R<8> are groups =0, m and n =0; R<4> and R<5> are methyl and R<6> is ethenyl; R<3> is not hydroxyl or ethanoyloxy.
Patent DE-69607307-T2 (DE)
Inventor: WADOUX PIERRE
IPC: H02B1/052
Filed: 1996-12-05
Granted: 2000-07-13
Abstract: The spacer module includes end sections (34) which form openings (36) extending perpendicular to the side walls (20) and which are connected by an oblique middle section (35). Each of the sections have a single partition (36,37) whose transverse ends have their internal ridge reduced by a chamfer. One side of the channel has at least one cavity with a recessed base belonging to one of the principal surfaces (18) to which they open out by apertures at the ends of the channel. The spacer snaps onto a standard support rail by means of a groove (22) in the rear surface (19).
Patent DE-69620440-T2 (DE)
Inventor: OKAYAMA CHIKASHI
IPC: C08L53/00
Filed: 1996-11-22
Granted: 2002-08-29
Abstract: A polypropylene composition for the production of various molded articles which are excellent in moldability, mold shrinkage factor on molding, rigidity, flexibility, impact resistance, in particular low-temperature impact resistance, transparency, gloss, stress-whitening resistance, and the balance thereof; various molded articles having the above properties; a propylene composition which is suitable for a base resin for the polypropylene composition; and a process for the production thereof. The propylene composition comprises a propylene homopolymer and a propylene-ethylene copolymer, the intrinsic viscosity of the copolymer (Ä eta ÜRC) is in the range of 1.7 to 2.8 dl/g, the intrinsic viscosity ratio of the homopolymer to the copolymer (Ä eta ÜRC/Ä eta ÜPP) is in the range of 0.7 to 1.2 and a product Ä(WPP/WRC) x (Ä eta ÜRC/Ä eta ÜPP)Ü of the weight ratio (WPP/WRC) of the homopolymer to the copolymer and the intrinsic viscosity ratio thereof is in the range of 1.0 to 3.0.
Patent DE-69621990-T2 (DE)
Inventor: PICAUD PHILIPPE
IPC: H04W88/02
Filed: 1996-09-06
Granted: 2003-01-23
Abstract: The terminal has a side wall with guide slots (1,2) which cooperate with side guides (31,41) having end protrusions (32,42) in a cover. The guide slots have an end section (11,21) which is of increased depth. The cover slides into the guide slots, and protrusions on the guide wall end snap lock into place on the mobile telephone guide slots. The cover is fixed immobile.
Patent DE-69630604-T2 (DE)
Inventor: BIRCH MARTIN
IPC: C07D405/14
Filed: 1996-07-02
Granted: 2004-09-23
Abstract: PCT No. PCT/EP96/02890 Sec. 371 Date Jan. 5, 1998 Sec. 102(e) Date Jan. 5, 1998 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/03071 PCT Pub. Date Jan. 30, 1997Compounds of formula I and pharmaceutically acceptable salts thereof in which A is methylene or O; B is methylene or O; g is 0,1,2,3 or 4; R1 is an optional substituent; U is an alkylene chain optionally substituted by one or more alkyl; Q represents a divalent group containing nitrogen atoms; and T represents CO.HET, have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive-compulsive behavior, panic attacks, social phobias, eating disorders and anorexia, cardiovascular and cerebrovascular disorders, non-insulin dependent diabetes mellitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress, prostatic hypertrophy, and spasticity.
Patent DE-69635427-T2 (DE)
Inventor: SCHELLENBERGER WILHELM
IPC: H01L21/304
Filed: 1996-08-09
Granted: 2006-07-27
Abstract: A method of drying a substrate surface (1), comprising:   dipping the substrate into a liquid bath (2); separating the substrate from the liquid bath (2), whereby the liquid of the liquid bath (2) comprises an aqueous HF solution (3), the substrate surface being hydrophobic upon separation from the liquid bath, the substrate being separated from the bath at a rate that permits the bath liquid to drain from the hydrophobic surface of the substrate to produce a dry substrate; and that a gas comprising an O2/O3 mixture that forms a hydrophilic surface on the substrate is directed over the surface of the substrate (1) after separating the substrate (1) from the liquid bath.   <IMAGE>
Patent DE-69708882-T2 (DE)
Inventor: HOLBROOK MARK BURTON
IPC: G01B15/02
Filed: 1997-08-11
Granted: 2002-08-01
Abstract: The thickness of a thin layer structure is monitored during deposition or etching. The structure is illuminated with a predetermined energy (visible or near visible light or x-ray) and a modified parameter of the illumination is measured, which may be reflection intensity, transmission intensity or polarisation. The detected signal is examined by shape recognition techniques using adaptive digital filters.
Patent DE-69714553-T2 (DE)
Inventor: LLADO ABELLA JORDI
IPC: B23K26/08
Filed: 1997-04-25
Granted: 2003-04-10
Abstract: The invention relates to a system for marking or perforating by laser and to a marking or perforation process in said system, which is comprised of at least one laser (19) which produces a beam, a supply unit for at least one laser (19), a control means (12) with a control program which controls the laser (19), a deflector (16) particularly an optical-acoustic deflector which produces different beam deflection angles, in this case an optical system traversed by the beam, which produces a marking or a perforation configured like a matrix of points (nxm) on a surface of a product in relative motion between the product to be marked or perforated and the laser beam. The supply unit and/or the deflector (16) may be controlled by the control program. The system of the invention provides for a dynamic control of the marking or perforation resolution in a vertical direction. <IMAGE>
Patent DE-69714619-T2 (DE)
Inventor: ORSAT JEAN-MICHEL
IPC: E06B9/72
Filed: 1997-01-08
Granted: 2004-01-29
Abstract: The installation includes an electric motor (11) driving the roller blinds panel (1) which offers protection against the sun to raise or lower the panel. A control device includes a processing unit which operates by detection of the excess torque on the motor, or by detection of the loss of angular speed on the motor drive shaft. The control system also includes a bi-directional counter (13) and a memory holding the values corresponding to the arrival of the blinds at the top of its range, and at its bottom stop. The comparison of the speed and the state of the counter allows identification of the top and bottom stop regions. This allows distinction between the arrival of the blinds at one of the prescribed stop positions, and the presence of an obstacle restricting movement of the blinds.
Patent DE-69716720-T2 (DE)
Inventor: EATON BRUCE
IPC: C07C41/30
Filed: 1997-02-25
Granted: 2003-06-12
Abstract: This invention discloses an improved method for the [2+2+2] cyclotrimerization reaction in aqueous solutions using a water soluble transition metal catalyst.
Patent DE-69801616-T2 (DE)
Inventor: WAGNER MATTHEW LINCOLN
IPC: B01F23/10
Filed: 1998-06-18
Granted: 2002-06-20
Abstract: A system provides an oxygen-bearing gas and gaseous reactant stream to a fluidized bed reactor using a sparger to entrain the oxygen-bearing gas into the reactant gas stream. A feed line couples the sparger to the reactor's fluidized bed and introduces the reactant gas stream and entrained oxygen-bearing gas directly into contact with the fluidized bed. A controller controls and maintains both the amount of oxygen-bearing gas and the gaseous reactant above an upper flammability limit, preferably with a safety margin of at least 10%. <IMAGE>
Patent DE-69806177-T2 (DE)
Inventor: RYAN E
IPC: F16D3/74
Filed: 1998-10-21
Granted: 2003-02-13
Abstract: Disclosed herein is an elastomeric coupling for transmitting torque between two shafts approximately aligned on a shaft axis, which coupling comprises a composite member including an elastomeric center element, and a shoe fabricated from a reinforced plastic material and including a first portion bonded to the center element, and a second portion extending axially from the first portion and from the center element, including apertured metallic inserts, and being adapted to be connected to one of the shafts.
Patent DE-69810938-T2 (DE)
Inventor: AOTSUKA TOMOJI
IPC: C07D403/04
Filed: 1998-04-10
Granted: 2003-11-06
Abstract: Antiinflammatory agents which are excellent in pharmacological effects and exhibit selective COX-2 inhibiting activity leading to an expectation of reduction in the adverse effects such as gastric mucosal disturbances. Compounds of general formula (I) have excellent antiinflammatory activity, and exhibit potent inhibitory action against COX-2 induced at an inflamed site with little inhibitory action against COX-1 always present in the stomach, kidney and so on, (wherein R<1> is hydrogen or halogeno; R<2> and R<3> are each hydrogen, halogeno, lower alkyl, lower alkoxy, hydroxyl or lower alkanoyloxy; R<4> is halogenated lower alkyl or lower alkyl; X is sulfur, oxygen or NH; and Y is lower alkylthio, lower alkylsulfonyl or sulfamoyl). Accordingly, drugs containing the compounds are useful as antiinflammatory agents reduced in the adverse effects such as gastric mucosal disturbances by virtue of the selective inhibitory activity of the compounds against COX-2. <CHEM>
Patent DE-69815347-T2 (DE)
Inventor: SAGAWA HIROAKI
IPC: A61K31/341
Filed: 1998-01-19
Granted: 2004-04-29
Abstract: 2,5-dihydroxytetrahydro-2-furancarboxylic acid represented by the following formula ÄIÜ, its optically active substance or salt thereof. <CHEM>
Patent DE-69826446-T2 (DE)
Inventor: ARSLAN M
IPC: G10L21/013
Filed: 1998-01-27
Granted: 2005-01-20
Abstract: A voice conversion system employs a codebook mapping approach to transforming a source voice to sound like a target voice. Each speech frame is represented by a weighted average of codebook entries. The weights represent a perceptual distance of the speech frame and may be refined by a gradient descent analysis. The vocal tract characteristics, represented by a line spectral frequency vector, the excitation characteristics, represented by a linear predictive coding residual, the duration, and the amplitude of the speech frame are transformed in the same weighted-average framework.
Patent DE-69830650-T2 (DE)
Inventor: COHN WILLIAM
IPC: A61B17/11
Filed: 1998-04-24
Granted: 2006-05-11
Abstract: The present invention relates to a surgical retractor that immobilizes tissue at a surgical site. A preferred embodiment, of the retractor is used during minimally invasive direct coronary bypass procedures to arrest movement of the grafting site while the heart continues pumping. Tape or thread can be used to connect the artery to the retractor with a holder.
Patent DE-69902096-T2 (DE)
Inventor: OELTGEN R
IPC: A61K38/08
Filed: 1999-04-30
Granted: 2003-02-27
Abstract: A method for treating ischemia by administering deltorphins to a mammal. Deltorphin I SEQ ID NO:1, deltorphin II SEQ ID NO:2 or combinations of deltorphins I SEQ ID NO:1 and II SEQ ID NO:2 may be administered. A deltorphin concentration of about 0.5-20 mg/kg, or alternatively 1-1000 mu g/kg body weight of the mammal in a physiologically acceptable formulation is administered up to four hours after an ischemic episode. Deltorphins may also be administered prior to or concurrently with onset of ischemia. Cerebral or spinal cord ischemia or ischemic heart disease may be treated using the method of the invention.
Patent DE-69914971-T2 (DE)
Inventor: LANDROT ALAIN C O GEC ALSTOM T
IPC: B61F5/30
Filed: 1999-06-17
Granted: 2004-07-29
Abstract: The railway vehicle bogie (1) has wheels (5) mounted on at least two axles (A,B). At least one longitudinal frame member (6) connects the axles at a middle section. The frame member is formed by an elastic strip forming a flattened loop. The claims also include a method of forming the sprung frame member
Patent DE-69915987-T2 (DE)
Inventor: KAWAMOTO TAKESHI
IPC: C07F7/18
Filed: 1999-12-07
Granted: 2005-01-05
Abstract: A process for recycling a silicone compound wherein the silicone compound is decomposed by employing an alkyl carbonate and a compound containing active hydrogen group in the presence of a catalyst, and silicone monomers and/or silicone oligomers are recovered from the decomposed silicone compound. Silicone monomers and/or silicone oligomers are produced without producing any byproduct, and no step for removal by separation is needed in an after process, and therefore the implementation is easy.
Patent DE-69916106-T2 (DE)
Inventor: MARCUSSEN JAN
IPC: A61F13/02
Filed: 1999-11-25
Granted: 2005-02-17
Abstract: A layered product in a package ready for non-touch application which product comprises a cover layer to which an adhesive layer is unreleasably fastened and a release layer which is releasably fastened to the adhesive layer, and which package comprises a top layer and a bottom layer where the top layer is next to the cover layer and the bottom layer is next to the adhesive layer or the release layer and the top and bottom layer are releasably sealed to each other isolating the adhesive layer from the surroundings, and where the cover layer is releasably fastened to the top layer.
Patent DE-69919869-T2 (DE)
Inventor: SCHLINGENSIEPEN KARL-HERMANN
IPC: C12N15/11
Filed: 1999-06-10
Granted: 2005-09-29
Abstract: Medicament comprising a combination of at least one inhibitor of the effect of a substance negatively effecting an immune response, the substance selected from the group consisting of TGF-beta and its receptors, VEGF and its receptors, interleukin 10 (IL-10) and its receptors, PGE2 and its receptors, wherein the inhibitor has a molecular weight of less than 100 kDa and at least one stimulator positively effecting an immune response.
Patent DE-69925627-T2 (DE)
Inventor: BERG ALLEN
IPC: A61M25/01
Filed: 1999-11-05
Granted: 2005-10-27
Abstract: A bypass graft conduit (200) is installed in the circulatory system of a patient using apparatus which facilitates performing most or all of the necessary work intraluminally (i.e., via lumens of the patient's circulatory system). A guide structure such as a wire (600) is installed in the patient via circulatory system lumens (210) so that a portion (220) of the guide structure extends along the desired path of the bypass conduit, which bypass conduit path is outside the circulatory system as it exists prior to installation of the bypass graft. The bypass graft is then introduced into the patient along the guide structure and connected at each of its ends to the circulatory system using connectors (60) that form fluid-tight annular openings from the bypass graft lumen into the adjacent circulatory system lumens. The guide structure is then pulled out of the patient.
Patent DE-69927516-T2 (DE)
Inventor: SHIBATA MASARU
IPC: C07D239/48
Filed: 1999-11-15
Granted: 2006-03-16
Abstract: A pyrimidinylbenzimidazole or triazinylbenzimidazole derivative represented by the general formula ÄIÜ: <CHEM> (wherein A is N or CR<3>, each of R<1> and R<2> which are independent of each other, is a hydrogen atom, a halogen atom, a (C1-C6) alkyl group, a (C2-C6) alkenyl group, a (C2-C6) alkynyl group, a (C3-C6) cycloalkyl group, a (C1-C4) haloalkyl group, a (C1-C6) alkoxy group, a (C2-C6) alkenyloxy group, a (C2-C6) alkynyloxy group, a (C3-C6) cycloalkoxy group, a (C1-C4) haloalkoxy group, a cyano (C1-C4) alkyloxy group, a (C1-C4) alkoxy (C1-C4) alkyloxy group, a (C3-C6) cycloalkyl (C1-C4) alkoxy group, a benzyloxy group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ, a (C1-C6) alkylthio group, a (C1-C4) alkoxy (C1-C4) alkyl group, a phenoxy group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ, a (C1-C4) alkylcarbonyl group, a formyl group, a phenyl group, a di(C1-C4) alkylamino group, a cyano group or a (C1-C6) alkylsulfonyl group, R<3> is a hydrogen atom, a (C1-C6) alkyl group, a (C1-C6) alkoxy group or a halogen atom, X is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a (C1-C6) alkyl group, a (C2-C6) alkenyl group, a (C2-C6) alkynyl group, a (C3-C6) cycloalkyl group, a benzyl group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ, a (C1-C6) alkoxy group, a (C2-C6) alkenyloxy group, a (C2-C6) alkynyloxy group, a (C1-C6) alkylthio group, a (C1-C6) alkylsulfonyl group, a phenoxy group, a (C1-C4) alkoxy (C1-C4) alkyl group, a (C1-C4) haloalkyl group, a (C1-C4) haloalkoxy group, a (C1-C4) alkylcarbonyl group, a (C1-C4) alkoxycarbonyl group, an amino group, a mono(C1-C4) alkylamino group, a di(C1-C4) alkylamino group, an anilino group or a phenyl group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ, Y is a halogen atom, a nitro group, a cyano group, a (C1-C6) alkyl group, a (C2-C6) alkenyl group, a (C2-C6) alkynyl group, a (C1-C6) alkoxy group, a (C2-C6) alkenyloxy group, a (C2-C6) alkynyloxy group, a (C1-C4) haloalkoxy group, a (C1-C6) alkylthio group, a (C1-C4) alkoxy (C1-C4) alkyl group, a (C1-C4) haloalkyl group, a (C1-C4) alkylcarbonyl group, a (C1-C4) alkoxycarbonyl group, a benzoyl group, an amino group, a mono(C1-C4) alkylamino group, a di(C1-C4) alkylamino group, a phenyl group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ or a phenoxy group Äsaid group may be substituted by a halogen atom, a (C1-C4) alkyl group or a (C1-C4) alkoxy groupÜ, and n is 0 or an integer of from 1 to 3ü.
Patent DE-69929233-T2 (DE)
Inventor: BARNABAS VIJAYARANI
IPC: C11D17/06
Filed: 1999-10-22
Granted: 2006-09-07
Abstract: The present invention relates to fabric care methods for restoring and/or rejuvenating color of worn, faded fabric, by applying to said fabric a fabric color care composition which comprises: water soluble and/or water dispersible polymers; surfactant capable of forming a bilayer structure; and mixtures thereof. Optionally, the composition can contain other ingredients to provide additionally fabric care benefits, and/or to improve performance and formulatability. The composition is preferably applied as small particle size droplets, escpecially from spray container which preferably are in association with a set of instructions for use.
Patent DE-69930013-T2 (DE)
Inventor: NODA ISAO
IPC: A61L15/62
Filed: 1999-12-13
Granted: 2006-10-26
Abstract: The present invention relates to biodegradable PHA copolymers comprising at least two randomly repeating monomer units. The present invention further relates to a plastic article comprising a biodegradable copolymer, wherein the biodegradable copolymer comprises at least two randomly repeating monomer units (RRMU) wherein the first RRMU has structure (I), wherein R<1> is H, or C1 or C2 alkyl, and n is 1 or 2; the second RRMU has structure (II) and wherein at least 50 % of the RRMUs have the structure of the first RRMU. The present invention further relates to an absorbent article comprising a liquid pervious topsheet, a liquid impervious backsheet comprising a film comprising a PHA of the present invention and an absorbent core copositioned between the topsheet and the backsheet.
Patent DE-69930287-T2 (DE)
Inventor: HERAJAERVI JUHA
IPC: H04Q7/38
Filed: 1999-11-10
Granted: 2006-07-27
Abstract: A method and a system for charging for message communication, e.g. short messages, in intelligent network applications and especially for charging for message communication by a prepaid subscriber. For charging an intelligent network subscriber for message communication, the message communication bills of the intelligent network subscribers are retrieved from the data collected for message communication charging and the bills are used to update the charging data of the intelligent network. This action is preferably performed periodically.
Patent DE-69934225-T2 (DE)
Inventor: GRANOFF M
IPC: A61P31/04
Filed: 1999-05-28
Granted: 2007-09-27
Abstract: The present invention is directed to a combination vaccine for  Neisseria meningitidis  comprising outer membrane proteins from serogroup B and oligosaccharides from serogroup C, and its use for the prevention or treatment of disease.
Patent HU-E026853-T2 (HU)
Title: Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
Inventor: BIEMANS RALPH LEON
IPC: A61K39/09
Filed: 2008-06-24
Abstract: The present invention discloses an immunogenic composition comprising  S. pneumoniae  capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.